Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The anticoagulants market is forecasted to achieve significant growth in the coming few years with a forecast CAGR (compound annual growth rate) of 9%, as per The Business Research Company’s market report!

Read More On The Anticoagulants Market Report 2022 – https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

The Anticoagulants Market Size In 2022 And Forecast
The global anticoagulants market is expected to grow from $36.50 billion in 2021 to $40.34 billion in 2022 at a compound annual growth rate (CAGR) of 10.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The anticoagulant market is expected to reach $56.94 billion in 2026 at a CAGR of 9%.

The anticoagulants market consists of sales of anticoagulants by entities (organizations, sole traders, and partnerships) that manufacture anticoagulant drugs which keep blood vessels open and prevent the formation of blood clots.

Request for A Sample Of The Global Anticoagulants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp

Increase In Cardiovascular Diseases Is Driving The Growth Of The Anticoagulants Market
According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide in 2019, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.

Competitive Landscape And The Regional Analysis Of The Anticoagulants Market

Major players in the anticoagulants market are GlaxoSmithKline plc., Pfizer Inc., Sanofi, Mylan, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo, Alexion Pharmaceuticals Inc., Otsuka and Leo Pharma.

Additionally, as per TBRC’s research – North America was the largest region in the anticoagulants market in 2021 holding the largest market share.

The Anticoagulants Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the anticoagulants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the anticoagulants market

ACTIV-4 Trials – A Key Trend In The Anticoagulants Market
The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19 related blood clotting in adults.

Anticoagulants Market Segmentation By The Business Research Company
1) By Drug Class: Factor Xa Inhibitor, Heparin and LMWH, Vitamin K Antagonist, Others
2) By Route of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation or Flutter, Coronary Artery Disease, Others
5) By End-User: Hospitals, Homecare, Specialty Centers, Others

Here Are Some Reports Related To The Anticoagulants Market –
Cancer Vaccines Global Market Report 2022
DTP Vaccines Global Market Report 2022
Monoclonal Antibodies (MAbs) Global Market Report 2022

Get In Touch With Us – Call us at:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found This Article Helpful? Share It On: